Ethylvinyl Acetate (EVA) Vaginal Ring Delivery System Study

• Status: Terminated
• Trial end date: 2013-06-01
• Target enrollment: 0
• Participant gender: Female

Summary

This research study is looking at how well a new drug delivery system, called the vaginal ring, works to get hormones into your body as a form of birth control.

• Phase: Phase 1/Phase 2
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: Massachusetts General Hospital
• Collaborator: Combinent

Criteria

Inclusion Criteria:

1. A history of normal regular menstrual cycles (25-35 days);

2. A normal physical examination;

3. A body mass index (BMI) between 19 & 29

4. A normal CBC, normal Prolactin level, normal LFT's

5. A negative urinary hCG at the initiation of each study; and

6. An agreement to refrain from attempting to conceive during the experimental cycle and the cycle thereafter by either abstinence and/or use of a barrier method of contraception.